These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20819167)

  • 1. TDP-43 proteinopathy in familial motor neurone disease with TARDBP A315T mutation: a case report.
    Cairns NJ; Perrin RJ; Schmidt RE; Gru A; Green KG; Carter D; Taylor-Reinwald L; Morris JC; Gitcho MA; Baloh RH
    Neuropathol Appl Neurobiol; 2010 Dec; 36(7):673-9. PubMed ID: 20819167
    [No Abstract]   [Full Text] [Related]  

  • 2. TDP-43 A315T mutation in familial motor neuron disease.
    Gitcho MA; Baloh RH; Chakraverty S; Mayo K; Norton JB; Levitch D; Hatanpaa KJ; White CL; Bigio EH; Caselli R; Baker M; Al-Lozi MT; Morris JC; Pestronk A; Rademakers R; Goate AM; Cairns NJ
    Ann Neurol; 2008 Apr; 63(4):535-8. PubMed ID: 18288693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-occurrence of progressive anarthria with an S393L TARDBP mutation and ALS within a family.
    Praline J; Vourc'h P; Guennoc AM; Veyrat-Durebex C; Corcia P
    Amyotroph Lateral Scler; 2012 Jan; 13(1):155-7. PubMed ID: 21830990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive motor weakness in transgenic mice expressing human TDP-43.
    Stallings NR; Puttaparthi K; Luther CM; Burns DK; Elliott JL
    Neurobiol Dis; 2010 Nov; 40(2):404-14. PubMed ID: 20621187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43.
    Gendron TF; Rademakers R; Petrucelli L
    J Alzheimers Dis; 2013; 33 Suppl 1(Suppl 1):S35-45. PubMed ID: 22751173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical aspects of TDP-43 proteinopathy, neurofilament inclusion body disease and dementias lacking distinctive proteinopathy.
    Josephs KA
    Handb Clin Neurol; 2008; 89():377-82. PubMed ID: 18631761
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 Proteinopathy.
    Spiller KJ; Cheung CJ; Restrepo CR; Kwong LK; Stieber AM; Trojanowski JQ; Lee VM
    J Neurosci; 2016 Jul; 36(29):7707-17. PubMed ID: 27445147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival in the pre-senile dementia frontotemporal lobar degeneration with TDP-43 proteinopathy: effects of genetic, demographic and neuropathological variables.
    Armstrong RA
    Folia Neuropathol; 2016; 54(2):137-48. PubMed ID: 27543771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First Japanese autopsy case showing LRRK2 mutation G2019S and TDP-43 proteinopathy.
    Sakuwa M; Adachi T; Suzuki Y; Yoshida K; Fukuda H; Miura H; Adachi Y; Hanajima R
    Parkinsonism Relat Disord; 2021 Oct; 91():85-87. PubMed ID: 34543853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy.
    McKee AC; Gavett BE; Stern RA; Nowinski CJ; Cantu RC; Kowall NW; Perl DP; Hedley-Whyte ET; Price B; Sullivan C; Morin P; Lee HS; Kubilus CA; Daneshvar DH; Wulff M; Budson AE
    J Neuropathol Exp Neurol; 2010 Sep; 69(9):918-29. PubMed ID: 20720505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New terminology for a common TDP-43 proteinopathy.
    Kurucu H; Spires-Jones T; Smith C
    Lancet Neurol; 2019 Aug; 18(8):714-715. PubMed ID: 31202672
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of TDP-43 Proteinopathy Onset and Propagation.
    Chen HJ; Mitchell JC
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible behavioral phenotypes in a conditional mouse model of TDP-43 proteinopathies.
    Alfieri JA; Pino NS; Igaz LM
    J Neurosci; 2014 Nov; 34(46):15244-59. PubMed ID: 25392493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative patterns of motor cortex proteinopathy across ALS genotypes.
    Nolan M; Scott C; Gamarallage MP; Lunn D; Carpenter K; McDonough E; Meyer D; Kaanumalle S; Santamaria-Pang A; Turner MR; Talbot K; Ansorge O
    Acta Neuropathol Commun; 2020 Jul; 8(1):98. PubMed ID: 32616036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rodent models of TDP-43: recent advances.
    Tsao W; Jeong YH; Lin S; Ling J; Price DL; Chiang PM; Wong PC
    Brain Res; 2012 Jun; 1462():26-39. PubMed ID: 22608070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autopsy of an Elderly Man With Incidentally Diagnosed TDP-43 Proteinopathy.
    Hata Y; Yoshida K; Nishida N
    Alzheimer Dis Assoc Disord; 2018; 32(2):158-161. PubMed ID: 29278558
    [No Abstract]   [Full Text] [Related]  

  • 17. Cortical degeneration in frontotemporal lobar degeneration with TDP-43 proteinopathy caused by progranulin gene mutation.
    Armstrong RA
    Int J Neurosci; 2014 Dec; 124(12):894-903. PubMed ID: 24494724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptic exon incorporation occurs in Alzheimer's brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43.
    Sun M; Bell W; LaClair KD; Ling JP; Han H; Kageyama Y; Pletnikova O; Troncoso JC; Wong PC; Chen LL
    Acta Neuropathol; 2017 Jun; 133(6):923-931. PubMed ID: 28332094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correspondence regarding: TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 2010:69;918-29.
    Armon C; Miller RG
    J Neuropathol Exp Neurol; 2011 Jan; 70(1):97-8; author reply 98-100. PubMed ID: 21173609
    [No Abstract]   [Full Text] [Related]  

  • 20. Oligodendroglial response in the spinal cord in TDP-43 proteinopathy with motor neuron involvement.
    Rohan Z; Matej R; Rusina R; Kovacs GG
    Neurodegener Dis; 2014; 14(3):117-24. PubMed ID: 25115814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.